在使用机器学习方法预测喘时,GWAS风险位置和临床数据的重要性
Zan-Mei Qin1, Si-Qiao Liang1, Jian-Xiong Long2
1Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Combinatorial chemistry & high throughput screening
|June 6, 2023
概括
将全基因组关联研究 (GWAS) 的遗传数据与临床信息相结合,可以改善喘预测. 机器学习模型确定了关键的遗传位置和诸如家族史和BMI等因素,以更好地评估喘风险.
科学领域:
- 遗传学和基因组学 在
- 计算生物学 计算生物学
- 流行病学 流行病学
背景情况:
- 喘是一种复杂的呼吸系统疾病,具有多因素的病因.
- 了解遗传和临床风险因素对于准确的喘预测和管理至关重要.
研究的目的:
- 开发和评估用于喘预测的机器学习模型.
- 确定喘的关键遗传和临床预测因素.
主要方法:
- 一个病例控制研究,涉及123名喘患者和100名来自珠安的人口的对照.
- 使用聚合酶链反应检测全基因组关联研究 (GWAS) 风险位置.
- 应用机器学习算法来整合GWAS数据和临床信息.
主要成果:
- 仅使用GWAS风险位置或临床数据的模型实现曲线下面积 (AUC) 分别为64.3%和71.4%.
- 使用XGBoost的组合模型达到79.7%的最高AUC.
- 最重要的预测因素包括特定的GWAS位点 (rs3117098,rs7775228,rs2305480,rs4833095),家族史和体重指数.
结论:
- 将全基因组关联研究 (GWAS) 风险位置与临床数据相结合,显著提高了喘预测的准确性.
- 机器学习模型通过识别关键风险因素,为喘病原体提供了宝贵的见解.
相关概念视频
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
462
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
462
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Leukotriene Modifiers
375
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
375


